IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.3040
+0.0061 (2.05%)
At close: May 12, 2025, 4:00 PM
0.3040
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT

IGC Pharma Market Cap

IGC Pharma has a market cap or net worth of $24.22 million as of May 12, 2025. Its market cap has decreased by -11.59% in one year.

Market Cap
24.22M
Enterprise Value
24.02M
1-Year Change
-11.59%
Ranking
Category
Stock Price
$0.30

Market Cap Chart

Since May 24, 2006, IGC Pharma's market cap has decreased from $69.50M to $24.22M, a decrease of -65.14%. That is a compound annual growth rate of -5.40%.

History

DateMarket Cap% Change
May 12, 202524.20M-6.92%
Dec 31, 202426.00M46.07%
Dec 29, 202317.80M5.33%
Dec 30, 202216.90M-66.13%
Dec 31, 202149.90M-22.52%
Dec 31, 202064.40M158.63%
Dec 31, 201924.90M-72.49%
Dec 31, 201890.50M222.06%
Dec 29, 201728.10M255.70%
Dec 30, 20167.90M102.56%
Dec 31, 20153.90M-58.06%
Dec 31, 20149.30M19.23%
Dec 31, 20137.80M-3.70%
Dec 31, 20128.10M32.79%
Dec 30, 20116.10M-22.78%
Dec 31, 20107.90M-53.80%
Dec 31, 200917.10M101.18%
Dec 31, 20088.50M-89.66%
Dec 31, 200782.20M0.74%
Dec 29, 200681.60M17.41%
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 659.45B
Johnson & Johnson 371.06B
UnitedHealth Group 345.29B
AbbVie 326.55B
Novo Nordisk 297.79B
Abbott Laboratories 231.82B
Novartis AG 214.71B
AstraZeneca 211.14B
Market Cap Rankings